Wearable health monitor developer Current Health secured $11.5m in a Legal & General-backed round that took its total funding to nearly $22m.

Immunos Therapeutics has picked up Pfizer Ventures as an investor as it looks to move its lead immuno-oncology drug candidate into clinical testing.

Inscripta has now accumulated more than $259m altogether from investors including Institut Mérieux, and will use the capital to further expand its genome engineering platform.

OSF HealthCare-backed Regroup Telehealth has merged with fellow psychiatric services provider InSight Telepsychiatry having raised more than $19m in funding.

Immunos Therapeutics has picked up Pfizer Ventures as an investor as it looks to move its lead immuno-oncology drug candidate into clinical testing.

Ascension Ventures was among the participants in the first close of neurovascular catheter developer Imperative Care's series C round, which it expects to close at $85m.

Ramsay Health Care was among the investors in a $19.8m first funding round for Harrison.ai, which has already formed partnerships with Virtus Health and I-Med.

Epidarex Capital has launched a new drug discovery initiative providing seed funding and hands-on support to nurture fledgling projects.

Alexandria Venture Investments has backed a series A round for Jasper Therapeutics, which is developing a conditioning agent for patients awaiting stem cell transplants.

Agilent Technologies contributed to a $50m round for the tissue-imaging technology developer, which has earmarked the funds for product development.